The aim of this study was to analyse and compare the effects of GH and IGF-1 supplementation in liver, adipokines and muscular tissue in an NAFLD experimental model that resembles features of early NAFLD stages including obesity and insulin resistance. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.